NEW YORK (GenomeWeb) – For about two decades, widespread use of point-of-care molecular testing technologies has seemed to be just beyond the horizon, but microfluidics' manufacturing costs may have limited their uptake.

Researchers at the Fraunhofer Center for Manufacturing Innovation in Brookline, Massachusetts have now developed a low-cost method to construct continuous-flow real-time PCR devices, which could potentially push POC molecular testing further into the mainstream.